All Press Releases
Pertamina saves US$402.46 million amid rising global oil prices
PT Pertamina
•
Sep 03, 2022 07:00 HKT/SGT
State-owned oil and gas company PT Pertamina succeeded in saving operational costs of around Rp6 trillion (US$402.46 million) until July 2022 through several efficiency programs amid rising world oil prices that increased fuel production costs.She explained that energy companies around the world are
亞太地區吸引了50%的全球臨床試驗 根據新的GlobalData報告
Novotech Health Holdings Pte Ltd
•
Sep 02, 2022 21:00 HKT/SGT
亞太地區領先的生物技術臨床研究機構 Novotech 在一份題為“亞太地區臨床試驗的演變”的報告中發布了新的市場數據。該報告由 GlobalData 編寫，並確認“亞太地區 (APAC) 地區是 2017 年至 2021 年全球臨床試驗格局的最大貢獻者，佔分析期間進行的試驗的 50% 以上。”點擊下載報告 https://novotech-cro.com/whitepapers/evolution-clinical-trials-asia-pacific-region-compared-us-and-eu5此外，GlobalData 研究發現，該地區所有臨床試驗階段的增長均高於美國和歐盟5。在
亚太地区吸引了50%的全球临床试验 根据新的GlobalData报告
Novotech Health Holdings Pte Ltd
•
Sep 02, 2022 21:00 HKT/SGT
亚太地区领先的生物技术临床研究机构 Novotech 在一份题为“亚太地区临床试验的演变”的报告中发布了新的市场数据。 该报告由 GlobalData 编写，并确认“亚太地区 (APAC) 地区是 2017 年至 2021 年全球临床试验格局的最大贡献者，占分析期间进行的试验的 50% 以上。”点击下载报告 https://novotech-cro.com/whitepapers/evolution-clinical-trials-asia-pacific-region-compared-us-and-eu5此外，GlobalData 研究发现，该地区所有临床试验阶段的增长均高于美国和欧盟5。
Jefferies maintains Buy rating on Yeahka (9923.HK)
YEAHKA LIMITED
•
Sep 02, 2022 19:30 HKT/SGT
Yeahka (9923.HK), the leading payment-based technology platform in China, announced its 2022 interim results in late August. During the period, total revenue climbed 17.1% to RMB1,641.8 million, gross profit rose 52.1% to RMB529.3 million, and gross margin increased from 24.8% to 32.2%."Yeahka&
医思健康主席邓志辉增持公司股份 对集团业务未来发展态势维持信心
EC Healthcare
•
Sep 02, 2022 17:33 HKT/SGT
香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，集团主席、行政总裁及执行董事邓志辉先生（「邓先生」）于2022年 9月1日于公开市场新增购入107,000股，涉资约58.7万港元，每股股份平均价格约5.4905港元。是次进一步增持完成后，邓先生持有的股份数为722,034,610股，持股比例由61.26%增至61.27%。医思健康主席、执行董事兼行政总裁邓志辉先生表示︰「受益于集团对资讯科技，服务，品牌的持续性投入，集团2023财年第一季度（2022年4-6月）录得不少于8.6亿港元的销售额，业务展现良好恢复态势。医思
醫思健康主席鄧志輝增持公司股份 對集團業務未來發展態勢維持信心
EC Healthcare
•
Sep 02, 2022 17:32 HKT/SGT
香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，集團主席、行政總裁及執行董事鄧志輝先生（「鄧先生」）於2022年 9月1日於公開市場新增購入107,000股，涉資約58.7萬港元，每股股份平均價格約5.4905港元。是次進一步增持完成後，鄧先生持有的股份數為722,034,610股，持股比例由61.26%增至61.27%。醫思健康主席、執行董事兼行政總裁鄧志輝先生表示︰「受益於集團對資訊科技，服務，品牌的持續性投入，集團2023財年第一季度（2022年4-6月）錄得不少於8.6億港元的銷售額，業務展現良好恢復態勢。醫思
EC Healthcare Chairman Mr. Eddy Tang Increases Shareholding, Demonstrating Full Confidence in the Group's Future Development
EC Healthcare
•
Sep 02, 2022 17:31 HKT/SGT
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that on 1 September 2022, the Group's Chairman, Executive Director and Chief
Legend Capital: The Logic of Technology Investment Has Changed
Legend Capital
•
Sep 02, 2022 17:05 HKT/SGT
Legend Capital recently announced that it made its 100th IPO following the listing of its AI medical portfolio company Lunit on the KOSDAQ market on 21 July 2022. In addition, Legend Capital's CRO portfolio company R&G Pharmastudies was successfully listed on the ChiNext of Shenzhen Stock E
Leading VC Firm, Black3Lab Capital Announces Investment in Ripe Web 3.0 Sectors
ACN Newswire
•
Sep 02, 2022 17:00 HKT/SGT
NEW YORK, NY, Sept 2, 2022 - (ACN Newswire) - Black3Lab Capital, a venture capital firm built to empower web 3.0 companies with potential for global mass adoption, has announced investments in ripe web 3.0 sectors. Black3Lab's proposed $50 to $100 million fund will focus on building a genuinely feas
The Growhub Innovations Company Announces Joint Project with Koufuku Group to Explore Asean Market Penetration
ACN Newswire
•
Sep 02, 2022 17:00 HKT/SGT
The GrowHub Innovations Company ("The GrowHub"), Asia Pacific's only Web3-enabled plug-and-play ecosystem builder for food traceability and carbon credits, and KOUFUKU GROUP, a Japanese food company with over 50 years of history, have signed an MoU partnership for a joint project on m
WIKA Books Sales of Rp7.18 Trillion in Q2-2022
PT Wijaya Karya (Persero) Tbk.
•
Sep 02, 2022 15:00 HKT/SGT
PT WIJAYA KARYA (Persero) Tbk. [IDX: WIKA] successfully booked a gross profit of Rp627.24 billion in Q2-2022 or 14.8% higher on a year-on-year basis (YoY) as recorded in the financial statement for the period ended on 30 June 2022. This figure was supported by the Company's sales of Rp7.18 tril
Younger Colorectal Cancer Population Highlights the Importance of Early Screening, Highly Sensitive Test Product Prenetics has Launched the Market
Prenetics Group Limited
•
Sep 02, 2022 14:33 HKT/SGT
Colorectal cancer (CRC) has become one of the main cancers threatening the health of human beings. In the United States and China, CRC has ranked among the top three cancers that lead to death.CRC screening has been proven to be one of the most effective tools for preventing colorectal cancer. Resea
APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report
Novotech Health Holdings Pte Ltd
•
Sep 02, 2022 14:00 HKT/SGT
Novotech, the leading Asia Pacific biotech specialist CRO has released new market data in a report now available titled "Evolution of Clinical Trials in the Asia Pacific Region". The report was prepared by GlobalData and confirms that "the Asia-Pacific (APAC) region was the largest co
百奥赛图今日登陆港交所 硬核技术打通新药研发全链条
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
•
Sep 02, 2022 13:41 HKT/SGT
近年来，随着人口老龄化程度加深及慢性病人数的不断增长，社会对医疗保健的需求不断增加，在中国政府鼓励创新的系列政策支持下，底层创新生物医药领域已成为资本市场公认的风口。今日，作为临床阶段生物技术及临床前研究服务创收公司，百奥赛图正式登陆港交所主板，股份代号：02315.HK，由高盛与中金公司联席保荐。据悉，百奥赛图以专有基因编辑技术、转基因小鼠平台、综合动物病患模型及高通量体内抗体发现平台为依托，经过多年的发展，已经建立涵盖早期靶点认证及抗体生成到临床开发的全链条综合研发实力。硬核技术加持 底层创新能力助力多元服务创收根据招股书，百奥赛图依托自主研发的ESC/HR、EGE系统和SUPCE三大基
百奧賽圖今日登陸港交所 硬核技術打通新藥研發全鏈條
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
•
Sep 02, 2022 13:40 HKT/SGT
近年來，隨著人口老齡化程度加深及慢性病人數的不斷增長，社會對醫療保健的需求不斷增加，在中國政府鼓勵創新的系列政策支持下，底层创新生物医药领域已成為資本市場公認的風口。今日，作為臨床階段生物技術及臨床前研究服務創收公司，百奧賽圖正式登陸港交所主板，股份代號：02315.HK，由高盛與中金公司聯席保薦。據悉，百奧賽圖以專有基因編輯技術、轉基因小鼠平台、綜合動物病患模型及高通量體內抗體發現平台為依託，經過多年的發展，已經建立涵蓋早期靶點認證及抗體生成到臨床開發的全鏈條綜合研發實力。硬核技術加持 底層創新能力助力多元服務創收根據招股書，百奥赛图依托自主研发的ESC/HR、EGE系统和SUPCE三大基
BoB Financial and Snapdeal Launch Co-Branded JCB RuPay Contactless Credit Card
Bank of Baroda
•
Sep 02, 2022 13:30 HKT/SGT
BOB Financial Solutions Limited (BFSL), the wholly-owned subsidiary of Bank of Baroda (BoB) and Snapdeal in partnership with National Payments Corporation of India (NPCI) and JCB International Co. Ltd. have announced the launch of the Snapdeal BoB JCB RuPay Credit Card. The card is designed keeping
Manila Protection of Online Content Summit Builds Off High Hopes for Efficient and Effective Site Blocking Measures in New House Bill
ACN Newswire
•
Sep 02, 2022 13:06 HKT/SGT
The Asia Video Industry Association (AVIA) and the Coalition Against Piracy (CAP) hosted a seminar earlier today in Manila to promote the protection of online content in a country that continues to have some of the highest levels of online piracy in Asia Pacific, levels that impede economic growth a
Seventh Belt and Road Summit draws to successful close
Bank of China
•
Sep 02, 2022 12:00 HKT/SGT
The seventh Belt and Road Summit, jointly organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), concluded yesterday (1 September). Continuing in the tradition of being a formal, substantial and high-quality event, the
科创助联控（03396.HK）中期业绩稳中有进
Legend Holdings
•
Sep 01, 2022 19:46 HKT/SGT
据阿思达克财经网报道，8月业绩期已近尾声，昨日超200间上市公司中期发榜。由于上半年资本市场受疫情及宏观形势等多方不确定因素影响，多数上市公司业绩承压，如此市况下，联想控股股份有限公司（3396.HK）发布中期成绩单，上半年收入升4%达人民币2,377亿元，归母净利录得21亿元较去年同期有所下降，公司解释话系由于资本市场波动影响所致，但从其业绩公告不难看出，联控基本盘稳健，产业运营板块逆势增长，且近年来持续加大科创领域投入及布局，相信会为企业的长期发展积蓄动能，值得关注其后续成长。多年来，联想控股深耕科创领域，也与内地政府倡导的「坚持把科技创新摆在国家发展全局的核心位置，全面谋划科技创新工作」
科創助聯控(3396)中期業績穩中有進
Legend Holdings
•
Sep 01, 2022 19:45 HKT/SGT
據阿思達克財經網報道，8月業績期已近尾聲，昨日超200間上市公司中期放榜。由於上半年資本市場受疫情及宏觀形勢等多方不確定因素影響，多數上市公司業績承壓，如此市況下，聯想控股股份有限公司（3396.HK）發佈中期成績單，上半年收入升4%達人民幣2,377億元，歸母淨利錄得21億元較去年同期有所下降，公司解釋話係由於資本市場波動影響所致，但從其業績公告不難看出，聯控基本盤穩健，產業運營板塊逆勢增長，且近年來持續加大科創領域投入及佈局，相信會為企業的長期發展積蓄動能，值得關注其後續成長。多年來，聯想控股深耕科創領域，也與內地政府倡導的「堅持把科技創新擺在國家發展全局的核心位置，全面謀劃科技創新工作」